Alnylam Pharmaceuticals
ALNY
#571
Rank
NZ$70.20 B
Marketcap
NZ$529.37
Share price
-1.18%
Change (1 day)
26.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company